The management of hormone-relapsed prostate cancer.
Parkinson
R W
RW
Austin
R H
RH
Parr
N J
NJ
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary*; D019008:Drug Resistance, Neoplasm; D005598:Fractures, Spontaneous / Q000209:etiology; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors
D018931:Antineoplastic Agents, Hormonal